INSIG1 and neoplasm: PCK1 with protein kinase activity can phosphorylate INSIG1/2, which leads to impaired binding of INSIG1/2 with intracellular lipids, thus promoting the activation of the SREBP signaling pathway and lipid synthesis of tumor cells (52).